Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical-devices: Archive
Henry Schein (HSIC) Extends Partnership With Special Olympics
by Zacks Equity Research
Henry Schein's (HSIC) extended collaboration with Special Olympics is likely to promote wellness and health education for athletes with ID around the world.
RMDNegative Net Change HSICNegative Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
Here's Why You Should Retain Zimmer Biomet (ZBH) Stock for Now
by Zacks Equity Research
Strong procedure recovery and progress on the four-pillar strategy bode well for Zimmer Biomet (ZBH).
ZBHNegative Net Change MEDPNegative Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
by Zacks Equity Research
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
DVAPositive Net Change ALGNNegative Net Change SENSNegative Net Change MEDPNegative Net Change
medical medical-devices
Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies
by Zacks Equity Research
Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.
DVAPositive Net Change ALGNNegative Net Change STXSNegative Net Change MEDPNegative Net Change
medical medical-devices
Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
by Zacks Equity Research
Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.
RMDNegative Net Change ALCNegative Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
by Zacks Equity Research
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
ECLNegative Net Change BAXNegative Net Change DVAPositive Net Change VEEVNegative Net Change
medical medical-devices
Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
by Zacks Equity Research
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
ECLNegative Net Change DVAPositive Net Change VEEVNegative Net Change GKOSNegative Net Change
medical medical-devices
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
by Zacks Equity Research
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
BSXNegative Net Change ECLNegative Net Change PHGPositive Net Change ALGNNegative Net Change
medical medical-devices
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
by Zacks Equity Research
QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.
RMDNegative Net Change QGENNegative Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
Should You Buy Newmont Corporation (NEM) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
NEMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Add The Cooper Companies (COO) to Your Portfolio
by Zacks Equity Research
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.
DVAPositive Net Change ALGNNegative Net Change COONegative Net Change MEDPNegative Net Change
medical medical-devices
QIAGEN (QGEN) to Enhance Forensics With New Partnership
by Zacks Equity Research
QIAGEN's (QGEN) recent deal advances a novel test for its QIAcuity digital PCR devices. This will enhance forensics by improving the quantification of DNA in human samples.
RMDNegative Net Change QGENNegative Net Change MEDPNegative Net Change EHCNegative Net Change
medical medical-devices
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
BSXNegative Net Change ECLNegative Net Change ISRGNegative Net Change ALGNNegative Net Change
medical medical-devices
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now
by Zacks Equity Research
Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
ECLNegative Net Change DVAPositive Net Change VEEVNegative Net Change ITGRNegative Net Change
medical medical-devices
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
by Zacks Equity Research
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
ECLNegative Net Change DVAPositive Net Change VEEVNegative Net Change CTLTNegative Net Change
medical medical-devices
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
by Zacks Equity Research
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.
BSXNegative Net Change ECLNegative Net Change OFIXNegative Net Change ALGNNegative Net Change
medical medical-devices
Teleflex (TFX) Expands Vascular Access Portfolio With New Launch
by Zacks Equity Research
Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.
RMDNegative Net Change TFXNegative Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change AMNNegative Net Change
earnings medical medical-devices
PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
by Zacks Equity Research
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change PACBPositive Net Change
earnings medical medical-devices
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
by Zacks Equity Research
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
RMDNegative Net Change HAEPositive Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CMMBPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Snap (SNAP) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SNAPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Byline Bancorp (BY) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
First Community Bancshares (FCBC) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FCBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings
by Moumi Mondal
Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.
MDTNegative Net Change VCYTPositive Net Change BRBRNegative Net Change HIMSPositive Net Change
medical medical-devices